Yuannang Biotechnology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 8

Yuannang Biotechnology General Information

Description

Developer of musculoskeletal regenerative medical materials designed for clinical applications. The company offers integrated drug pipelines, clinical trial data, and therapeutic insights, enabling pharmaceutical researchers and healthcare innovators to accelerate development and improve treatment efficacy.

Contact Information

Website
www.origobio.com.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 3, Number 265 Chengrui Street, Xiasha Subdistrict
  • Qiantang District
  • Hangzhou, Zhejiang 900000
  • China
+86 0571
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Surgical Devices
Corporate Office
  • 3rd Floor, Building 3, Number 265 Chengrui Street, Xiasha Subdistrict
  • Qiantang District
  • Hangzhou, Zhejiang 900000
  • China
+86 0571

Yuannang Biotechnology Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yuannang Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A1) 29-Jun-2026 Completed Generating Revenue
3. Early Stage VC (Series A) 11-Sep-2025 Completed Generating Revenue
2. Early Stage VC 18-Dec-2024 Completed Generating Revenue
1. Secondary Transaction - Private 02-Aug-2023 Completed Generating Revenue
To view Yuannang Biotechnology’s complete valuation and funding history, request access »

Yuannang Biotechnology Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hangzhou Puhua Tianji Investment Growth/Expansion Minority
Hangzhou Talent Group Corporation Minority
Ningbo Danbei Venture Capital Partnership Growth/Expansion Minority
Puhua Capital Venture Capital Minority
Renai Group Holding Company Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Yuannang Biotechnology FAQs

  • When was Yuannang Biotechnology founded?

    Yuannang Biotechnology was founded in 2022.

  • Where is Yuannang Biotechnology headquartered?

    Yuannang Biotechnology is headquartered in Hangzhou, China.

  • What industry is Yuannang Biotechnology in?

    Yuannang Biotechnology’s primary industry is Biotechnology.

  • Is Yuannang Biotechnology a private or public company?

    Yuannang Biotechnology is a Private company.

  • What is Yuannang Biotechnology’s current revenue?

    The current revenue for Yuannang Biotechnology is .

  • How much funding has Yuannang Biotechnology raised over time?

    Yuannang Biotechnology has raised $14M.

  • Who are Yuannang Biotechnology’s investors?

    Hangzhou Puhua Tianji Investment, Hangzhou Talent Group, Ningbo Danbei Venture Capital Partnership, Puhua Capital, and Renai Group are 5 of 8 investors who have invested in Yuannang Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process